1974/06/22 by M. A. E. Ramsay, Michael A. E. Ramsay, T.M. Savege +5 · 2,919 citations
Medicine · #Anesthesia #Anesthesia and Sedative Agents #Cardiac, Anesthesia and Surgical Outcomes #Intensive Care Unit Cognitive Disorders #Intensive care medicine #Medicine #Pharmacology #Sedation #Sedative #Tachyphylaxis
paper · pdf · doi:10.1136/bmj.2.5920.656
published in BMJ 2(5920), 656-659
openalex publication_date 1974/06/22 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided "light sleep," allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.